Anja Schaible
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anja Schaible has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Peter Sauer
Interdisziplinäres Endoskopiezentrum, Universitätsklinikum Heidelberg, Heidelberg, Deutschland
6 shared publications Markus W. Büchler
Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
4 shared publicationsP. Sauer
Klinik für Gastroenterologie, Infektionskrankheiten und Vergiftung, Universitätsklinikum Heidelberg, Heidelberg, Deutschland
4 shared publicationsPeter Sauer
Department of Gastroenterology, University Hospital Heidelberg, Heidelberg, Germany
4 shared publicationsF. Chahoud
3 shared publicationsP Sauer
Universitätsklinikum Heidelberg, Innere Medizin IV/IEZ, Heidelberg, Deutschland
3 shared publications
Latest Publications
- 10 July 2021
- Published by Elsevier in Journal of Surgical Research
- Vol. 267, 516-526
Self-Expanding Metal Stents for Anastomotic Leaks After Upper Gastrointestinal Cancer Surgery
- 10 July 2021
- Published by Elsevier in Journal of Surgical Research
- Vol. 267, 516-526
Self-Expanding Metal Stents for Anastomotic Leaks After Upper Gastrointestinal Cancer Surgery
- 28 May 2021
- Published by Georg Thieme Verlag KG in Allgemein- und Viszeralchirurgie up2date
- Vol. 15 (03) , 255-267
Maligne Magenausgangsstenose: Duodenalstents zur Palliation
Patienten, die an einer malignen Magenausgangsstenose erkrankt sind, haben leider nur eine sehr limitierte Prognose. Klinische Symptome sind abdominelle Schmerzen, Übelkeit, Erbrechen und Mangelernährung. Die therapeutischen Bemühungen, ob chirurgisch oder endoskopisch, sollten darauf fokussiert sein, die Obstruktion zügig aufzuheben, eine Nahrungsaufnahme zu ermöglichen und somit die Lebensqualität für die verbleibende Zeit zu erhalten. Publication Date: 28 May 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 28 May 2021
- Published by Georg Thieme Verlag KG in Allgemein- und Viszeralchirurgie up2date
- Vol. 15 (03) , 255-267
Maligne Magenausgangsstenose: Duodenalstents zur Palliation
Patienten, die an einer malignen Magenausgangsstenose erkrankt sind, haben leider nur eine sehr limitierte Prognose. Klinische Symptome sind abdominelle Schmerzen, Übelkeit, Erbrechen und Mangelernährung. Die therapeutischen Bemühungen, ob chirurgisch oder endoskopisch, sollten darauf fokussiert sein, die Obstruktion zügig aufzuheben, eine Nahrungsaufnahme zu ermöglichen und somit die Lebensqualität für die verbleibende Zeit zu erhalten. Publication Date: 28 May 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 5 August 2020
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 9 (8) , e17516
Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Flexible sigmoidoscopy and colonoscopy are recommended screening options for colorectal cancer (CRC). Of these options, only colonoscopy which requires complete bowel cleansing and is more invasive but visualizes the entire colon and rectum is offered for CRC screening, but use of this offer has been very limited. Objective: To assess the potential for increasing use of endoscopic CRC screening and the detection of advanced colorectal neoplasms by offering the choice between use of flexible sigmoidoscopy and colonoscopy. Methods: The DARIO study includes a cross-sectional study (Part I), followed by a prospective two-arm randomized controlled intervention trial (Part II) with an associated biobank study (Part III). Participation is possible in part I only, parts I and II, or all three parts. After obtaining informed consent from the municipalities 12,000 people, aged 50-54 years, from the Rhine-Neckar region in Germany are randomly selected from residential lists of the responsible population registries and are invited to complete a standardized questionnaire to investigate the nature, frequency, timing, and results of previous colorectal cancer screening and eventual diagnostic colonoscopies. In study part II participants from study part I with no colonoscopy in the preceding 5 years are randomized into two arms: arm A offering screening colonoscopy only, and arm B offering both options, either screening colonoscopy or screening sigmoidoscopy, to investigate whether the screening offer for less invasive sigmoidoscopy leads to a higher use of endoscopic screening and a higher number of detected and removed neoplasms > 0.5cm (primary endpoint). Part III of the study will use samples from participants in study part II to construct a liquid and tissue biobank for the evaluation of less invasive methods of early detection of colon cancer and for the more detailed characterization of the detected neoplasms. Blood, urine, stool and saliva samples are taken before the endoscopy. Tissue samples are obtained from the neoplasms removed during endoscopy. Results: 10,568 randomly selected women and men aged 50-54 years living in the Rhine-Neckar-Region of Germany have been invited for participation, 1432 could not be invited because they reached the age of 55 at the time of contact, 2789 women and men participated in study part I. Study parts II and III are ongoing. Conclusions: This study will answer the question if alternative offers of either screening sigmoidoscopy or screening colonoscopy will increase utilization and effectiveness of endoscopic CRC screening compared to an exclusive offer of screening colonoscopy. In addition, alternative non-invasive screening tests will be developed and validated. Clinical Trial: The trial was registered during recruitment of the participants in www.drks.de on September 30, 2019: German Clinical Trials Register DRKS-ID: DRKS0000
- 5 August 2020
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 9 (8) , e17516
Open AccessEffects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Flexible sigmoidoscopy and colonoscopy are recommended screening options for colorectal cancer (CRC). Of these options, only colonoscopy which requires complete bowel cleansing and is more invasive but visualizes the entire colon and rectum is offered for CRC screening, but use of this offer has been very limited. Objective: To assess the potential for increasing use of endoscopic CRC screening and the detection of advanced colorectal neoplasms by offering the choice between use of flexible sigmoidoscopy and colonoscopy. Methods: The DARIO study includes a cross-sectional study (Part I), followed by a prospective two-arm randomized controlled intervention trial (Part II) with an associated biobank study (Part III). Participation is possible in part I only, parts I and II, or all three parts. After obtaining informed consent from the municipalities 12,000 people, aged 50-54 years, from the Rhine-Neckar region in Germany are randomly selected from residential lists of the responsible population registries and are invited to complete a standardized questionnaire to investigate the nature, frequency, timing, and results of previous colorectal cancer screening and eventual diagnostic colonoscopies. In study part II participants from study part I with no colonoscopy in the preceding 5 years are randomized into two arms: arm A offering screening colonoscopy only, and arm B offering both options, either screening colonoscopy or screening sigmoidoscopy, to investigate whether the screening offer for less invasive sigmoidoscopy leads to a higher use of endoscopic screening and a higher number of detected and removed neoplasms > 0.5cm (primary endpoint). Part III of the study will use samples from participants in study part II to construct a liquid and tissue biobank for the evaluation of less invasive methods of early detection of colon cancer and for the more detailed characterization of the detected neoplasms. Blood, urine, stool and saliva samples are taken before the endoscopy. Tissue samples are obtained from the neoplasms removed during endoscopy. Results: 10,568 randomly selected women and men aged 50-54 years living in the Rhine-Neckar-Region of Germany have been invited for participation, 1432 could not be invited because they reached the age of 55 at the time of contact, 2789 women and men participated in study part I. Study parts II and III are ongoing. Conclusions: This study will answer the question if alternative offers of either screening sigmoidoscopy or screening colonoscopy will increase utilization and effectiveness of endoscopic CRC screening compared to an exclusive offer of screening colonoscopy. In addition, alternative non-invasive screening tests will be developed and validated. Clinical Trial: The trial was registered during recruitment of the participants in www.drks.de on September 30, 2019: German Clinical Trials Register DRKS-ID: DRKS0000
- Open Access
- 18 December 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial (Preprint)
BACKGROUND Flexible sigmoidoscopy and colonoscopy are recommended screening options for colorectal cancer (CRC). Despite colonoscopy being offered for CRC screening in Germany, the uptake of this offer has been very limited. OBJECTIVE The objective of this study was to assess the potential for increasing use of endoscopic CRC screening and the detection of advanced colorectal neoplasms by offering the choice between use of flexible sigmoidoscopy and colonoscopy. METHODS The DARIO study includes a cross-sectional study (part I), followed by a prospective 2-arm randomized controlled intervention trial (part II) with an associated biobank study (part III). Participation is possible in part I of the DARIO study only, parts I and II, or all 3 study parts. After obtaining informed consent from the municipalities, 12,000 people, aged 50-54 years, from the Rhine-Neckar region in Germany were randomly selected from residential lists of the responsible population registries and invited to complete a standardized questionnaire to investigate the nature, frequency, timing, and results of previous CRC screening and eventual diagnostic colonoscopies. In study part II participants from study part I with no colonoscopy in the preceding 5 years are randomized into 2 arms: arm A offering screening colonoscopy only, and arm B offering both options, either screening colonoscopy or screening sigmoidoscopy. The primary endpoint is the proportion of participants in whom colorectal neoplasms >0.5 cm are detected and removed at screening endoscopy. The secondary endpoints are the detection rate of any neoplasm and use of any endoscopic screening. Part III of the study will use samples from participants in study part II to construct a liquid and tissue biobank for the evaluation of less invasive methods of early detection of colon cancer and for the more detailed characterization of the detected neoplasms. Blood, urine, stool, and saliva samples are taken before the endoscopy. Tissue samples are obtained from the neoplasms removed during endoscopy. RESULTS A total of 10,568 from 12,000 randomly selected women and men aged 50-54 years living in the Rhine-Neckar-Region of Germany have been invited for participation. The remaining 1432 (11.93%) could not be invited because they reached the age of 55 at the time of contact. Of those invited, 2785/10,568 (26.35%) participated in study part I; 53.60% (1493/2785) of these participants were female. Study parts II and III are ongoing. CONCLUSIONS This study will answer the question if alternative offers of either screening sigmoidoscopy or screening colonoscopy will increase utilization and effectiveness of endoscopic CRC screening compared with an exclusive offer of screening colonoscopy. In addition, alternative noninvasive screening tests will be developed and validated. CLINICALTRIAL German Clinical Trials Register DRKS00018932; https://www.drks.de/drks_web/navigate.do? navigationId=trial.HTML&TRIAL_ID=DRKS00018932 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/17516
- 18 December 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEffects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial (Preprint)
BACKGROUND Flexible sigmoidoscopy and colonoscopy are recommended screening options for colorectal cancer (CRC). Despite colonoscopy being offered for CRC screening in Germany, the uptake of this offer has been very limited. OBJECTIVE The objective of this study was to assess the potential for increasing use of endoscopic CRC screening and the detection of advanced colorectal neoplasms by offering the choice between use of flexible sigmoidoscopy and colonoscopy. METHODS The DARIO study includes a cross-sectional study (part I), followed by a prospective 2-arm randomized controlled intervention trial (part II) with an associated biobank study (part III). Participation is possible in part I of the DARIO study only, parts I and II, or all 3 study parts. After obtaining informed consent from the municipalities, 12,000 people, aged 50-54 years, from the Rhine-Neckar region in Germany were randomly selected from residential lists of the responsible population registries and invited to complete a standardized questionnaire to investigate the nature, frequency, timing, and results of previous CRC screening and eventual diagnostic colonoscopies. In study part II participants from study part I with no colonoscopy in the preceding 5 years are randomized into 2 arms: arm A offering screening colonoscopy only, and arm B offering both options, either screening colonoscopy or screening sigmoidoscopy. The primary endpoint is the proportion of participants in whom colorectal neoplasms >0.5 cm are detected and removed at screening endoscopy. The secondary endpoints are the detection rate of any neoplasm and use of any endoscopic screening. Part III of the study will use samples from participants in study part II to construct a liquid and tissue biobank for the evaluation of less invasive methods of early detection of colon cancer and for the more detailed characterization of the detected neoplasms. Blood, urine, stool, and saliva samples are taken before the endoscopy. Tissue samples are obtained from the neoplasms removed during endoscopy. RESULTS A total of 10,568 from 12,000 randomly selected women and men aged 50-54 years living in the Rhine-Neckar-Region of Germany have been invited for participation. The remaining 1432 (11.93%) could not be invited because they reached the age of 55 at the time of contact. Of those invited, 2785/10,568 (26.35%) participated in study part I; 53.60% (1493/2785) of these participants were female. Study parts II and III are ongoing. CONCLUSIONS This study will answer the question if alternative offers of either screening sigmoidoscopy or screening colonoscopy will increase utilization and effectiveness of endoscopic CRC screening compared with an exclusive offer of screening colonoscopy. In addition, alternative noninvasive screening tests will be developed and validated. CLINICALTRIAL German Clinical Trials Register DRKS00018932; https://www.drks.de/drks_web/navigate.do? navigationId=trial.HTML&TRIAL_ID=DRKS00018932 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/17516
- 10 October 2018
- Published by Springer Nature in Der Chirurg
- Vol. 89 (12) , 945-951
Intrathorakale Anastomoseninsuffizienz nach Ösophagus- und Kardiaresektion
Die Anastomoseninsuffizienz ist nach wie vor die Hauptursache für Mortalität nach Ösophagus- und Kardiaresektion. Da sich in Deutschland die Endoskopie als erste diagnostische Maßnahme beim Verdacht auf eine Insuffizienz etabliert hat, hat die CAES auf der Basis des endoskopischen Befundes eine Definition und Schweregradklassifikation der Insuffizienz nach Ösophagusresektion entwickelt und validiert.
- 10 October 2018
- Published by Springer Nature in Der Chirurg
- Vol. 89 (12) , 945-951
Intrathorakale Anastomoseninsuffizienz nach Ösophagus- und Kardiaresektion
Die Anastomoseninsuffizienz ist nach wie vor die Hauptursache für Mortalität nach Ösophagus- und Kardiaresektion. Da sich in Deutschland die Endoskopie als erste diagnostische Maßnahme beim Verdacht auf eine Insuffizienz etabliert hat, hat die CAES auf der Basis des endoskopischen Befundes eine Definition und Schweregradklassifikation der Insuffizienz nach Ösophagusresektion entwickelt und validiert.
- 13 August 2018
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 56 (08) , e188
Programmierte Ballondilatationen bei dominanten Stenosen verbessern das transplantations-freie Überleben von Patienten mit Primär sklerosierender Cholangitis
Einleitung: Die endoskopische Therapie von dominanten Stenosen (DS) wird für symptomatische Patienten mit Primär sklerosierender Cholangitis (PSC) empfohlen. Ziele: Vergleich eines regelmäßigen endoskopischen Überwachungs- und Therapieprotokolles bei PSC-Patienten im Gegensatz zu Patienten mit endoskopischer Therapie nur bei symptomatischer Cholestase/Cholangitis. Methodik: Prospektive Kohortenstudie über den Zeitraum 1987 – 2016. Zu Beginn der Studie wurde die PSC bei allen Patienten mittels ERC gesichert. Im Anschluss wurde allen Patienten ein programmiertes endoskopisches Überwachungsgprogramm mit jährlichen Kontroll-ERCs empfohlen. Bei Nachweis einer DS erfolgten wiederholte Ballondilatationen bis zur morphologischen Resolution der DS. Patienten, welche sich diesem programmierten Programm nicht anschlossen wurden klinisch, laborchemisch und bildmorphologisch (Ultraschall/MRT) überwacht und erhielte ERCs nur bei symptomatischer Cholestase/Cholangitis. Ergebnis: Insgesamt wurden 286 PSC Patienten eingeschlossen. 133 (46,5%) Patienten folgten dem empfohlenen endoskopischen Überwachungs- und Therapieprotokoll (Gruppe A). Die übrigen 153 (53,5%) Patienten erhielten eine ERC nur bei symptomatischer Cholestase/Cholangitis (Gruppe B). Zu Beginn der Studie gab es keinerlei Unterschied hinsichtlich der klinischen oder laborchemischen Parameter. Am Ende des fast dreißigjährigen Beobachtungszeitraumes zeigte sich ein signifikant längeres transplantations-freies Überleben für Gruppe A verglichen mit Gruppe B (Median: 17,9 vs. 15,2 Jahre; log-rank: p = 0,008). In der Subgruppen-Analyse bestand der vorteilhafte Effekt nur bei Patienten mit DS (17,8 vs. 11,1 Jahre; log-rank: p < 0,001), nicht jedoch bei Patienten ohne DS (21,0 vs. 18,7 Jahre; log-rank: p = 0,8). Die multivariate Regressionsanalyse bestätigt CED (p = 0,03), DS (p = 0,006), höheren Mayo Risk Score (p = 0,02) und Teilnahme an der programmierten Endoskopie (p = 0,005) als unabhängige Risikofaktoren für ein längeres transplantations-freies Überleben. Schlussfolgerung: Eine programmierte endoskopische Überwachungs- und Therapiestrategie mit wiederholten Ballondilatationen bis zur morphologischen Resolution einer DS verbessert das transplantations-freie Überleben von Patienten mit PSC.
- 13 August 2018
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 56 (08) , e188
Programmierte Ballondilatationen bei dominanten Stenosen verbessern das transplantations-freie Überleben von Patienten mit Primär sklerosierender Cholangitis
Einleitung: Die endoskopische Therapie von dominanten Stenosen (DS) wird für symptomatische Patienten mit Primär sklerosierender Cholangitis (PSC) empfohlen. Ziele: Vergleich eines regelmäßigen endoskopischen Überwachungs- und Therapieprotokolles bei PSC-Patienten im Gegensatz zu Patienten mit endoskopischer Therapie nur bei symptomatischer Cholestase/Cholangitis. Methodik: Prospektive Kohortenstudie über den Zeitraum 1987 – 2016. Zu Beginn der Studie wurde die PSC bei allen Patienten mittels ERC gesichert. Im Anschluss wurde allen Patienten ein programmiertes endoskopisches Überwachungsgprogramm mit jährlichen Kontroll-ERCs empfohlen. Bei Nachweis einer DS erfolgten wiederholte Ballondilatationen bis zur morphologischen Resolution der DS. Patienten, welche sich diesem programmierten Programm nicht anschlossen wurden klinisch, laborchemisch und bildmorphologisch (Ultraschall/MRT) überwacht und erhielte ERCs nur bei symptomatischer Cholestase/Cholangitis. Ergebnis: Insgesamt wurden 286 PSC Patienten eingeschlossen. 133 (46,5%) Patienten folgten dem empfohlenen endoskopischen Überwachungs- und Therapieprotokoll (Gruppe A). Die übrigen 153 (53,5%) Patienten erhielten eine ERC nur bei symptomatischer Cholestase/Cholangitis (Gruppe B). Zu Beginn der Studie gab es keinerlei Unterschied hinsichtlich der klinischen oder laborchemischen Parameter. Am Ende des fast dreißigjährigen Beobachtungszeitraumes zeigte sich ein signifikant längeres transplantations-freies Überleben für Gruppe A verglichen mit Gruppe B (Median: 17,9 vs. 15,2 Jahre; log-rank: p = 0,008). In der Subgruppen-Analyse bestand der vorteilhafte Effekt nur bei Patienten mit DS (17,8 vs. 11,1 Jahre; log-rank: p < 0,001), nicht jedoch bei Patienten ohne DS (21,0 vs. 18,7 Jahre; log-rank: p = 0,8). Die multivariate Regressionsanalyse bestätigt CED (p = 0,03), DS (p = 0,006), höheren Mayo Risk Score (p = 0,02) und Teilnahme an der programmierten Endoskopie (p = 0,005) als unabhängige Risikofaktoren für ein längeres transplantations-freies Überleben. Schlussfolgerung: Eine programmierte endoskopische Überwachungs- und Therapiestrategie mit wiederholten Ballondilatationen bis zur morphologischen Resolution einer DS verbessert das transplantations-freie Überleben von Patienten mit PSC.
- 3 October 2017
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 402 (8) , 1167-1173
Significant decrease of mortality due to anastomotic leaks following esophageal resection: management makes the difference
Anastomotic leakage is the most frequent cause of postoperative mortality following esophageal surgery. However, no gold standard for diagnosing and managing leakage has been established. Continuous clinical judgment is extremely important; therefore, to optimize the management of leakage, we established a special group for decision-making in cases of suspected leakage in the early postoperative period.
- 3 October 2017
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 402 (8) , 1167-1173
Significant decrease of mortality due to anastomotic leaks following esophageal resection: management makes the difference
Anastomotic leakage is the most frequent cause of postoperative mortality following esophageal surgery. However, no gold standard for diagnosing and managing leakage has been established. Continuous clinical judgment is extremely important; therefore, to optimize the management of leakage, we established a special group for decision-making in cases of suspected leakage in the early postoperative period.
- 28 July 2016
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 401 (6) , 805-812
Role of endoscopy to predict a leak after esophagectomy
After esophageal surgery, many centers conduct a routine diagnostic test before reintroducing oral intake. However, the clinical value in asymptomatic patients has been questioned. Therefore, we left this decision to the discretion of the operating surgeon and documented the data prospectively.
- 28 July 2016
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 401 (6) , 805-812
Role of endoscopy to predict a leak after esophagectomy
After esophageal surgery, many centers conduct a routine diagnostic test before reintroducing oral intake. However, the clinical value in asymptomatic patients has been questioned. Therefore, we left this decision to the discretion of the operating surgeon and documented the data prospectively.
- Open Access
- 26 July 2016
- Published by Springer Nature in Trials
- Vol. 17 (1) , 1-9
Acupuncture to improve tolerance of diagnostic esophagogastroduodenoscopy in patients without systemic sedation: results of a single-center, double-blinded, randomized controlled trial (DRKS00000164)
Sedation prior to esophagogastroduodenoscopy is widespread and increases patient comfort. However, it demands additional trained personnel, accounts for up to 40 % of total endoscopy costs and impedes rapid hospital discharge. Most patients lose at least one day of work. 98 % of all serious adverse events occurring during esophagogastroduodenoscopy are ascribed to sedation. Acupuncture is reported to be effective as a supportive intervention for gastrointestinal endoscopy, similar to conventional premedication. We investigated whether acupuncture during elective diagnostic esophagogastroduodenoscopy could increase the comfort of patients refusing systemic sedation. We performed a single-center, double-blinded, placebo-controlled superiority trial to compare the success rates of elective diagnostic esophagogastroduodenoscopies using real and placebo acupuncture. All patients aged 18 years or older scheduled for elective, diagnostic esophagogastroduodenoscopy who refused systemic sedation were eligible; 354 patients were randomized. The primary endpoint measure was the rate of successful esophagogastroduodenoscopies. The intervention was real or placebo acupuncture before and during esophagogastroduodenoscopy. Successful esophagogastroduodenoscopy was based on a composite score of patient satisfaction with the procedure on a Likert scale as well as quality of examination, as assessed by the examiner. From February 2010 to July 2012, 678 patients were screened; 354 were included in the study. Baseline characteristics of the two groups showed a similar distribution in all but one parameter: more current smokers were allocated to the placebo group. The intention-to-treat analysis included 177 randomized patients in each group. Endoscopy could successfully be performed in 130 patients (73.5 %) in the real acupuncture group and 129 patients (72.9 %) in the placebo group. Willingness to repeat the procedure under the same conditions was 86.9 % in the real acupuncture group and 87.6 % in the placebo acupuncture group. Esophagogastroduodenoscopy without sedation is safe and can successfully be performed in two-thirds of patients. Patients planned for elective esophagogastroduodenoscopy without sedation do not benefit from acupuncture of the Sinarteria respondens (Rs) 24 Chengjiang middle line, Pericard (Pc) 6 Neiguan bilateral, or Dickdarm (IC) 4 Hegu bilateral, according to traditional Chinese medicine meridian theory. DRKS00000164. Registered on 10 December 2009.
- 26 July 2016
- Published by Springer Nature in Trials
- Vol. 17 (1) , 1-9
Open AccessAcupuncture to improve tolerance of diagnostic esophagogastroduodenoscopy in patients without systemic sedation: results of a single-center, double-blinded, randomized controlled trial (DRKS00000164)
Sedation prior to esophagogastroduodenoscopy is widespread and increases patient comfort. However, it demands additional trained personnel, accounts for up to 40 % of total endoscopy costs and impedes rapid hospital discharge. Most patients lose at least one day of work. 98 % of all serious adverse events occurring during esophagogastroduodenoscopy are ascribed to sedation. Acupuncture is reported to be effective as a supportive intervention for gastrointestinal endoscopy, similar to conventional premedication. We investigated whether acupuncture during elective diagnostic esophagogastroduodenoscopy could increase the comfort of patients refusing systemic sedation. We performed a single-center, double-blinded, placebo-controlled superiority trial to compare the success rates of elective diagnostic esophagogastroduodenoscopies using real and placebo acupuncture. All patients aged 18 years or older scheduled for elective, diagnostic esophagogastroduodenoscopy who refused systemic sedation were eligible; 354 patients were randomized. The primary endpoint measure was the rate of successful esophagogastroduodenoscopies. The intervention was real or placebo acupuncture before and during esophagogastroduodenoscopy. Successful esophagogastroduodenoscopy was based on a composite score of patient satisfaction with the procedure on a Likert scale as well as quality of examination, as assessed by the examiner. From February 2010 to July 2012, 678 patients were screened; 354 were included in the study. Baseline characteristics of the two groups showed a similar distribution in all but one parameter: more current smokers were allocated to the placebo group. The intention-to-treat analysis included 177 randomized patients in each group. Endoscopy could successfully be performed in 130 patients (73.5 %) in the real acupuncture group and 129 patients (72.9 %) in the placebo group. Willingness to repeat the procedure under the same conditions was 86.9 % in the real acupuncture group and 87.6 % in the placebo acupuncture group. Esophagogastroduodenoscopy without sedation is safe and can successfully be performed in two-thirds of patients. Patients planned for elective esophagogastroduodenoscopy without sedation do not benefit from acupuncture of the Sinarteria respondens (Rs) 24 Chengjiang middle line, Pericard (Pc) 6 Neiguan bilateral, or Dickdarm (IC) 4 Hegu bilateral, according to traditional Chinese medicine meridian theory. DRKS00000164. Registered on 10 December 2009.
- Open Access
- 4 April 2016
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 2 (1) , 18
Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial
- 4 April 2016
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 2 (1) , 18
Open AccessImmediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial